Elena Ridloff's Net Worth
$1.85 Million
Who is Elena Ridloff?
Elena Ridloff has an estimated net worth of $1.85 Million. This is based on reported shares across multiple companies, which include Kronos Bio, Inc., ACADIA PHARMACEUTICALS INC, and Kymera Therapeutics, Inc..
SEC CIK
Elena Ridloff's CIK is 0001772518
Past Insider Trading and Trends
2021 was Elena Ridloff's most active year for acquiring shares with 10 total transactions. Elena Ridloff's most active month to acquire stocks was the month of May. 2021 was Elena Ridloff's most active year for disposing of shares, totalling 5 transactions. Elena Ridloff's most active month to dispose stocks was the month of March. 2019 saw Elena Ridloff paying a total of $569,160.00 for 134,528 shares, this is the most they've acquired in one year. In 2019 Elena Ridloff cashed out on 72,000 shares for a total of $1,787,853.45, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Kronos Bio, Inc. (KRON) Snapshot price: $0.9601
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +81.16% | 11.33K |
—
|
—
| 25.3K |
Jun 25
| |||
Form 4
| +430.91% | 11.33K |
—
|
—
| 13.96K |
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
∞
| 2.63K |
$19.00 | $49,970.00 | 2.63K |
Oct 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACADIA PHARMACEUTICALS INC (ACAD) Snapshot price: $16.07
EVP and CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +26.53% | 2.21K |
$20.33 | -$20,980.56 | 10.55K |
Apr 29 - Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
| +113.79% | 4.44K |
$50.61 | -$103,801.11 | 8.34K |
Feb 4
| |||
Form 4
| +77.72% | 1.71K |
$53.34 | -$54,193.44 | 3.9K |
Jan 6
| |||
Form 4
|
∞
| 2.19K |
$37.86 | -$559,034.00 | 2.19K |
Scheduled
|
Apr 29 - Apr 30
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
|
—
|
0
|
$32.74 | -$1,218,693.45 |
0
|
Scheduled
|
Dec 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kymera Therapeutics, Inc. (KYMR) Snapshot price: $45.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||